Effects of the 21-aminosteroid U-74389G on ischemia and reperfusion injury of the ascending colon in horses.

This research paper investigates the effect of the drug U-74389G on injuries caused by lack of blood supply and subsequent restoration of blood supply (ischemia and reperfusion) in the ascending colon of horses. It found that U-74389G had no significant effect on inflammation markers, but it did help preserve the surface area of the colon’s mucosal layer during the reperfusion period.

Study Design and Methodology

• Sixteen horses were randomly divided into three groups for the experiment, subjected to different dosages of solutions containing the drug U-74389G: one group received only vehicle (control), a second group received a low dosage of the drug (3mg/kg) and the last group received a high dosage (10mg/kg).
• The solutions were administered prior to the reperfusion stage, after the ascending colon of each horse had undergone 2 hours of ischemia.
• Throughout this process, biopsies of full-thickness colonic tissue were taken at various intervals for further analysis.

Measurements and Findings

• The tissue samples were analyzed for concentration of malondealdehyde (MDA) and myeloperoxidase activity, both used as indicators of inflammation and resultant tissue damage related to ischemia and reperfusion.
• MDA concentration and myeloperoxidase activity were found to be increased during the ischemia and reperfusion stages, but not by a statistically significant amount. Administration of U-74389G did not significantly affect these indicators.
• However, the lower dosage of the drug was observed to have a tendency to reduce myeloperoxidase activity during the initial stages of reperfusion.
• In the vehicle-only group, reduced mucosal surface area of the colon was observed due to ischemia and continued into the reperfusion period.
• Administration of both low and high dosages of U-74389G prevented this reduction in mucosal surface area during reperfusion, which was statistically significant at certain intervals.
• For all groups, an initial reduction in mucosal volume was observed, which then increased in the first 60 minutes of reperfusion.

Conclusions

• While the 21-aminosteroid U-74389G did not have a significant effect on the MDA concentration and myeloperoxidase activity (key markers of inflammation), its administration did seem to have a protective effect on the mucosal surface area during the reperfusion stage, suggesting that it may offer some protection against ischemia-reperfusion injury in the colon.